A pipeline for the production of antibody fragments for structural studies using transient expression in HEK 293T cells

Protein Expression and Purification

Volumn 62, Issue 1, 2008, Pages 83-89

  Nettleship, Joanne E ^a   Ren, Jingshan ^a   Rahman, Nahid ^a   Berrow, Nick S ^a   Hatherley, Deborah ^b   Neil Barclay, A ^b   Owens, Raymond J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antibody fragments; Fabs; Transient expression; X ray crystallography

Indexed keywords

CD200R1 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; GENE VECTOR; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PROTEIN CONFORMATION; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; BASE SEQUENCE; CELLS, CULTURED; CRYSTALLOGRAPHY, X-RAY; GENETIC VECTORS; IMMUNOGLOBULIN FAB FRAGMENTS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RECEPTORS, CELL SURFACE;

EID: 52949116784     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.06.017     Document Type: Article

References (42)

1. Kovari L.C., Momany C., and Rossmann M.G. The use of antibody fragments for crystallization and structure determinations. Structure 3 (1995) 1291-1293
2. Hunte C., and Michel H. Crystallization of membrane proteins mediated by antibody fragments. Curr. Opin. Struct. Biol. 12 (2002) 503-508
3. C. Hunte, C. Münke, Application of antibody fragments as crystallization enhancers, in: T. Dingermann, D. Steinhilber, G. Folkers (Eds.), Molecular Biology in Medicinal chemistry, 2005, pp. 300-322.
4. Air G.M., Webster R.G., Colman P.M., and Laver W.G. Distribution of sequence differences in influenza N9 neuraminidase of tern and whale viruses and crystallization of the whale neuraminidase complexed with antibodies. Virology 160 (1987) 346-351
5. Karpusas M., Lucci J., Ferrant J., Benjamin C., Taylor F.R., Strauch K., Garber E., and Hsu Y.-M. Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody. Structure 9 (2001) 321-329
6. Shore D.A., Teyton L., Dwek R.A., Rudd P.M., and Wilson I.A. Crystal structure of the TCR co-receptor CD8αα in complex with monoclonal antibody YTS 105.18 Fab fragment at 2.88 A resolution. J. Mol. Biol. 358 (2006) 347-354
7. Fuh G., Wu P., Liang W.-C., Ultsch M., Lee C.V., Moffat B., and Wiesmann C. Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the AvastinTM Fab. J. Biol. Chem. 281 (2006) 6625-6631
8. Li B., Russell S.J., Compaan D.M., Totpal K., Marsters S.A., Ashkenazi A., Cochran A.G., Hymowitz S.G., and Sidhu S.S. Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists. J. Mol. Biol. 361 (2006) 522-536
9. Rothlisberger D., Pos K.M., and Plückthun A. An antibody library for stabilizing and crystallizing membrane proteins - selecting binders to the citrate carrier CitS. FEBS Lett. 564 (2004) 340-348
10. Evans E.J., Esnouf R.M., Manso-Sancho R., Gilbert R.J.C., James J.R., Yu C., Fennelly J.A., Vowles C., Hanke T., Walse B., Hunig T., Sorensen P., Stuart D.I., and Davis S.J. Crystal structure of a soluble CD28-Fab complex. Nat. Immunol. 6 (2005) 271-279
11. Reid C., Rushe M., Jarpe M., Van Vlijmen H., Dolinski B., Qian F., Cachero T.G., Cuervo H., Yanachkova M., Nwankwo C., Wang X., Etienne N., Garber E., Bailly V., deFougerolles A., and Boriack-Sjodin P.A. Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody. Protein Eng. Des. Sel. 19 (2006) 317-324
12. Ewert S., Huber T., Honegger A., and Pluckthun A. Biophysical properties of human antibody variable domains. J. Mol. Biol. 325 (2003) 531-553
13. Plückthun A., Krebber A., Horn U., Knüpfer U., Wenderoth R., Nieba L., Proba K., and Riesenberg D. Producing antibodies in E. coli From PCR to fermentation. In: McCafferty J., Hoogenboom H.R., and Chiswell D.J. (Eds). Antibody Engineering a Practical Approach (1996), Oxford University Press, Oxford 203-252
14. Samuelsson A., Yari F., Hinkula J., Ersoy O., Norrby E., and Persson M.A.A. Human antibodies from phage libraries: neutralizing activity against human immunodeficiency virus type 1 equally improved after expression as Fab and IgG in mammalian cells. Eur. J. Immunol. 26 (1996) 3029-3034
15. Persson M.A.A., Samuelsson A., Yari F., and Hinkula J. Comparisons of expression in procaryotic and eucaryotic hosts of human recombinant Fab molecules. Immunotechnology 2 (1996) 289
16. Sambrook J., and Russell D.W. Chapter 16: Introducing Cloned Genes into Cultured Mammalian Cells, Molecular Cloning: a Laboratory Manual (2001), Cold Spring Harbor Laboratory Press, New York
17. Gurtu V., Yan G., and Zhang G. IRES bicistronic expression vectors for efficient creation of stable mammalian cell lines. Biochem. Biophys. Res. Commun. 229 (1996) 295-298
18. Iba Y., Kaneko T., Ekida T., Miyata K., Inouye K., Kurosawa Y., and Yasukawa K. A new system for the expression of recombinant antibody in mammalian cells. Biotechnol. Lett. 17 (1995) 135-138
19. Letarte M., Voulgaraki D., Hatherley D., Foster-Cuevas M., Saunders N.J., and Barclay A.N. Analysis of leukocyte membrane protein interactions using protein microarrays. BMC Biochem. 6 (2005) 2
20. Brooke G., Holbrook J.D., Brown M.H., and Barclay A.N. Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family. J. Immunol. 173 (2004) 2562-2570
21. Berrow N.S., Alderton D., Sainsbury S., Nettleship J., Assenberg R., Rahman N., Stuart D.I., and Owens R.J. A versatile ligation-independent cloning method suitable for high-throughput expression screening applications. Nucleic Acids Res. 35 (2007) e45
22. Essono S., Frobert Y., Grassi J., Creminon C., and Boquet D. A general method allowing the design of oligonucleotide primers to amplify the variable regions from immunoglobulin cDNA. J. Immunol. Methods 279 (2003) 251-266
23. Wang Z., Raifu M., Howard M., Smith L., Hansen D., Goldsby R., and Ratner D. Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3′ to 5′ exonuclease activity. J. Immunol. Methods 233 (2000) 167-177
24. Aricescu A.R., Lu W., and Jones E.Y. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr. 62 (2006) 1243-1250
25. Nettleship J.E., Brown J., Groves M.R., and Geerlof A. Methods for protein characterization by mass spectrometry thermal shift (ThermoFluor) assay and multiangle or static light scattering. In: Kobe B., Guss M., and Huber T. (Eds). Structural Proteomics: High-Throughput Methods (2008), Humana Press 299-318
26. Wright G.J., Cherwinski H., Foster-Cuevas M., Brooke G., Puklavec M.J., Bigler M., Song Y., Jenmalm M., Gorman D., McClanahan T., Liu M.R., Brown M.H., Sedgwick J.D., Phillips J.H., and Barclay A.N. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J. Immunol. 171 (2003) 3034-3046
27. Hatherley D., Harlos K., Dunlop D.C., Stuart D.I., and Barclay A.N. The structure of the macrophage signal regulatory protein alpha (SIRPα) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors. J. Biol. Chem. 282 (2007) 14567-14575
28. Walter T.S., Diprose J.M., Mayo C.J., Siebold C., Pickford M.G., Carter L., Sutton G.C., Berrow N.S., Brown J., Berry I.M., Stewart-Jones G.B., Grimes J.M., Stammers D.K., Esnouf R.M., Jones E.Y., Owens R.J., Stuart D.I., and Harlos K. A procedure for setting up high-throughput nanoliter crystallization experiments Crystallization workflow for initial screening automated storage imaging and optimization. Acta Crystallogr. D 61 (2005) 651-657
29. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. In: Carter Jr. C.W., and Sweet R.M. (Eds). Meth Enzymol.: Macromolecular Crystallography, Part A (1997), Academic Press, New York 307-326
30. The CCP4 suite: programs for protein crystallography, Acta Crystallogr. D 50 (1994) 760-763.
31. Sawicki M.W., Ng P.C., Burkhart B.M., Pletnev V.Z., Higashiyama T., Osawa Y., and Ghosh D. Structure of an activity suppressing Fab fragment to cytochrome P450 aromatase: insights into the antibody-antigen interactions. Mol. Immunol. 36 (1999) 423-432
32. Schuermann J.P., Prewitt S.P., Davies C., Deutscher S.L., and Tanner J.J. Evidence for structural plasticity of heavy chain complementarity-determining region 3 in antibody-ssDNA recognition. J. Mol. Biol. 347 (2005) 965-978
33. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60 (2004) 2126-2132
34. Carton J.M., Sauerwald T., Hawley-Nelson P., Morse B., Peffer N., Beck H., Lu J., Cotty A., Amegadzie B., and Sweet R. Codon engineering for improved antibody expression in mammalian cells. Protein Expr. Purif. 55 (2007) 279-286
35. Whittle N., Adair J., Lloyd C., Jenkins L., Devine J., Schlom J., Raubitschek A., Colcher D., and Bodmer M. Expression in COS cells of a mouse-human chimaeric B72.3 antibody. Protein Eng. 1 (1987) 499-505
36. Burrows P., LeJeune M., and Kearney J.F. Evidence that murine pre-B cells synthesize μ heavy chains but no light chains. Nature 280 (1979) 838-840
37. Morrison S.L., and Scharff M.D. Heavy chain-producing variants of a mouse myeloma cell line. J. Immunol. 114 (1975) 655-659
38. Dul J.L., Aviel S., Melnick J., and Argon Y. Ig light chains are secreted predominantly as monomers. J. Immunol. 157 (1996) 2969-2975
39. Kutemeier G., Harloff C., and Mocikat R. Rapid isolation of immunoglobulin variable genes from cell lysates of rat hybridomas by polymerase chain reaction. Hybridoma 11 (1992) 23-32
40. Carroll W.L., Mendel E., and Levy S. Hybridoma fusion cell lines contain an aberrant kappa transcript. Mol. Immunol. 25 (1988) 991-995
41. Stanfield R.L., Zemla A., Wilson I.A., and Rupp B. Antibody elbow angles are influenced by their light chain class. J. Mol. Biol. 357 (2006) 1566-1574
42. Monnet C., Bettsworth F., Stura E.A., Du M.H.L., Menez R., Derrien L., Zinn-Justin S., Gilquin B., Sibai G., Battail-Poirot N., Jolivet M., Menez A., Arnaud M., Ducancel F., and Charbonnier J.B. Highly specific anti-estradiol antibodies: structural characterization and binding diversity. J. Mol. Biol. 315 (2002) 699-712